1.
Chinese Journal of Thoracic and Cardiovascular Surgery
;
(12): 504-507, 2022.
Artigo
em Chinês
| WPRIM
| ID: wpr-958434
RESUMO
Pulmonary hypertension is a progressive disease characterized by pulmonary vascular remodeling and eventually develops into right heart failure, which seriously affects the quality of life and safety of patients. Traditional drug therapy can alleviate disease progression, but the prognosis is poor.Mesenchymal stem cells have been shown to be effective in experimental pulmonary hypertension and right heart failure, which is an important research direction in the future.In this paper, the research progress of mesenchymal stem cells in pulmonary hypertension and right heart failure is reviewed.